Market Closed

CGEM
Cullinan Therapeutics
$ 10.28
0.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Cullinan Therapeutics News

Latest Cullinan Therapeutics Stock News & CGEM Headlines

New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
3 days ago | globenewswire.com
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
6 days ago | globenewswire.com
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
7 days ago | globenewswire.com
Does Cullinan Therapeutics (CGEM) Have the Potential to Rally 129.63% as Wall Street Analysts Expect?
18 days ago | zacks.com
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia
a month ago | globenewswire.com
New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
a month ago | globenewswire.com
Cullinan Therapeutics: Compelling Pullback For CLN-978's Potential In Autoimmune Diseases
2 months ago | seekingalpha.com
Cullinan Therapeutics Eyes December Data Catalyst for CLN-978 and CLN-049
2 months ago | marketbeat.com
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
2 months ago | globenewswire.com
Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CGEM
Cullinan Therapeutics
$ 10.28
0.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago